The German majority owner of CureVac AG has declared his commitment to making the company’s potential coronavirus vaccine available to people globally, from Germany. His comments come after Donald Trump was rumored to have offered the company a large amount of money to make it exclusively available to the US. Meanwhile, CureVac’s CEO, who met the US president earlier this month along with other biopharma executives, has been replaced.
Dietmar Hopp, the German software billionaire and biotech investor who owns more than 80% of Tübingen-based CureVac’s shares, said he...






